X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS JUBILANT LIFE SCIENCES DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x -10.9 15.6 - View Chart
P/BV x 0.2 4.6 3.5% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 DR. DATSONS LABS   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
JUBILANT LIFE SCIENCES
Mar-14
DR. DATSONS LABS/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs126187 67.2%   
Low Rs3165 47.5%   
Sales per share (Unadj.) Rs133.0364.3 36.5%  
Earnings per share (Unadj.) Rs0.26.8 2.2%  
Cash flow per share (Unadj.) Rs6.624.5 27.0%  
Dividends per share (Unadj.) Rs03.00 0.0%  
Dividend yield (eoy) %02.4 0.0%  
Book value per share (Unadj.) Rs128.8164.9 78.1%  
Shares outstanding (eoy) m31.66159.28 19.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.60.3 170.2%   
Avg P/E ratio x516.118.4 2,805.3%  
P/CF ratio (eoy) x11.85.1 230.3%  
Price / Book Value ratio x0.60.8 79.5%  
Dividend payout %043.8 0.0%   
Avg Mkt Cap Rs m2,47720,061 12.3%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m5611,052 0.5%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m4,21158,034 7.3%  
Other income Rs m79191 41.3%   
Total revenues Rs m4,28958,224 7.4%   
Gross profit Rs m5695,786 9.8%  
Depreciation Rs m2042,812 7.3%   
Interest Rs m4303,237 13.3%   
Profit before tax Rs m13-72 -17.6%   
Minority Interest Rs m0-286 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m6696 0.9%   
Profit after tax Rs m51,090 0.4%  
Gross profit margin %13.510.0 135.4%  
Effective tax rate %48.0-965.9 -5.0%   
Net profit margin %0.11.9 6.1%  
BALANCE SHEET DATA
Current assets Rs m6,85229,280 23.4%   
Current liabilities Rs m6,71138,912 17.2%   
Net working cap to sales %3.3-16.6 -20.2%  
Current ratio x1.00.8 135.7%  
Inventory Days Days16184 190.6%  
Debtors Days Days31851 628.3%  
Net fixed assets Rs m3,67355,712 6.6%   
Share capital Rs m317155 204.9%   
"Free" reserves Rs m3,76120,968 17.9%   
Net worth Rs m4,07826,265 15.5%   
Long term debt Rs m1,67117,169 9.7%   
Total assets Rs m12,63388,606 14.3%  
Interest coverage x1.01.0 105.3%   
Debt to equity ratio x0.40.7 62.7%  
Sales to assets ratio x0.30.7 50.9%   
Return on assets %3.44.9 70.5%  
Return on equity %0.14.2 2.8%  
Return on capital %7.711.6 66.3%  
Exports to sales %22.937.8 60.6%   
Imports to sales %14.316.5 86.7%   
Exports (fob) Rs m96421,933 4.4%   
Imports (cif) Rs m6029,567 6.3%   
Fx inflow Rs m96422,004 4.4%   
Fx outflow Rs m60711,749 5.2%   
Net fx Rs m35710,255 3.5%   
CASH FLOW
From Operations Rs m1,3458,026 16.8%  
From Investments Rs m-2,256-1,744 129.3%  
From Financial Activity Rs m-1,200-4,447 27.0%  
Net Cashflow Rs m-2,1111,834 -115.1%  

Share Holding

Indian Promoters % 4.5 45.6 9.9%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 0.0 8.7 -  
FIIs % 1.4 21.2 6.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 21.1 446.0%  
Shareholders   20,807 23,815 87.4%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   WOCKHARDT LTD.  J.B.CHEMICALS  BIOCON LTD  PFIZER  NATCO PHARMA  

Compare DR. DATSONS LABS With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY19); Net Profit Up 67.2% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 67.2% YoY). Sales on the other hand came in at Rs 23 bn (up 38.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY19); Net Profit Up 39.4% (Quarterly Result Update)

Jul 31, 2018 | Updated on Jul 31, 2018

For the quarter ended June 2018, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 39.4% YoY). Sales on the other hand came in at Rs 21 bn (up 30.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

Bharat Dynamics IPO: Worth Betting on Defence Manufacturing? (IPO)

Mar 12, 2018

Should you apply for the IPO of Bharat Dynamics, India's first state-owned missile manufacturer?

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS